Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Adavosertib
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Ovarian Serous Cystadenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Ovarian Serous Surface Papillary Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Prostate Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Rectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Skin Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Adavosertib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Alpelisib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Belinostat
Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Belinostat
Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P2
CCC
(52)
Cediranib
Breast Neoplasm
National Cancer Institute (NCI)
P2
CCC
(52)
Entinostat
Colon Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Fludeoxyglucose
Gastric Cancer
National Cancer Institute (NCI)
P2
CCC
(52)
Piflufolastat
Hepatocellular Carcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Pomalidomide
Acute Myeloid Leukemia
National Cancer Institute (NCI)
P2
CCC
(52)
Tas-102
Pancreatic Neoplasm
National Cancer Institute (NCI)
P2
CCC
(52)
Triadeno Vaccine
Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(52)
Triadeno Vaccine
Epithelial Neoplasm
National Cancer Institute (NCI)
P2
CCC
(52)
Vemurafenib
Histiocytic Sarcoma
National Cancer Institute (NCI)
P2
CCC
(52)
Vemurafenib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)
P2
CCC
(52)
Vemurafenib
Medulloblastoma
National Cancer Institute (NCI)
P2
CCC
(52)
Vorinostat
Myelodysplastic Syndrome With Excess Blasts-1
National Cancer Institute (NCI)
P2
CCC
(52)
Young Til
Melanoma
National Cancer Institute (NCI)
P2
CCC
(52)
Ziv-Aflibercept
Colorectal Cancer
National Cancer Institute (NCI)
P2
CCC
(52)
Showing 2226 to 2250 of 3,272 assets
Previous
Page 90 of 131
Next